Underglycosylation of IgA in IgA nephropathy: More than a diagnostic marker?

Kidney International

Volumn 71, Issue 11, 2007, Pages 1089-1091

  Roos, A ^a   Van Kooten, C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A;

CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; DISEASE MARKER; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOGLOBULIN BLOOD LEVEL; MESANGIUM CELL; MOLECULAR INTERACTION; NON INVASIVE MEASUREMENT; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; REVIEW;

EID: 34249311316     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5002262     Document Type: Note

References (15)

1. Barratt J, Feehally J. Treatment of IgA nephropathy. Kidney Int 2006; 69: 1934-1938.
2. Moldoveanu Z, Wyatt RJ, Lee JY et al. Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels. Kidney Int 2007; 71: 1148-1154.
3. Hiki Y, Odani H, Takahashi M et al. Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy. Kidney Int 2001; 59: 1077-1085.
4. Allen AC, Bailey EM, Brenchley PE et al. Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: observations in three patients. Kidney Int 2001; 60: 969-973.
5. Oortwijn BD, van der Boog PJM, Roos A et al. A pathogenic role for secretory IgA in IgA nephropathy. Kidney Int 2005; 69: 1131-1138.
6. Oortwijn BD, Roos A, Royle L et al. Differential glycosylation of polymeric and monomeric IgA: a possible role in glomerular inflammation in IgA nephropathy. J Am Soc Nephrol 2006; 17: 3529-3539.
7. Hiki Y, Tanaka A, Kokubo T et al. Analyses of IgA1 hinge glycopeptides in IgA nephropathy by matrix-assisted laser desorption/ionization timeof-flight mass spectrometry. J Am Soc Nephrol 1998; 9: 577-582.
8. Allen AC, Bailey EM, Barratt J et al. Analysis of IgA1 O-glycans in IgA nephropathy by fluorophoreassisted carbohydrate electrophoresis. J Am Soc Nephrol 1999; 10: 1763-1771.
9. Smith AC, de Wolff JF, Molyneux K et al. O-glycosylation of serum IgD in IgA nephropathy. J Am Soc Nephrol 2006; 17: 1192-1199.
10. Li G-S, Zhang H, Lv J-C et al. Variants of C1GALT1 gene are associated with the genetic susceptibility to IgA nephropathy. Kidney Int 2007; 71: 448-453.
11. Ju T, Cummings RD. Protein glycosylation: chaperone mutation in Tn syndrome. Nature 2005; 437: 1252.
12. Royle L, Roos A, Harvey DJ et al. Secretory IgA N- and O-glycans provide a link between the innate and adaptive immune systems. J Biol Chem 2003; 278: 20140-20153.
13. de Fijter JW, Eijgenraam JW, Braam CA et al. Deficient IgA1 immune response to nasal cholera toxin subunit B in primary IgA nephropathy. Kidney Int 1996; 50: 952-961.
14. Smith AC, Molyneux K, Feehally J, Barratt J. O-glycosylation of serum IgA1 antibodies against mucosal and systemic antigens in IgA nephropathy. J Am Soc Nephrol 2006; 17: 3520-3528.
15. Xu LX, Yan Y, Zhang JJ et al. The glycans deficiencies of macromolecular IgA1 is a contributory factor of variable pathological phenotypes of IgA nephropathy. Clin Exp Immunol 2005; 142: 569-575.